Abstract: A negative electrode including: a negative electrode current collector with a roughened surface; and a negative electrode active material layer provided on the negative electrode current collector. The negative electrode active material layer includes: negative electrode active material particles containing a compound of lithium, silicon, and oxygen; and a composite compound filled in interparticle gaps and a surface layer of the negative electrode active material particles, the composite compound at least containing chemically bonded carbon and oxygen atoms, the composite compound not being alloyed with the negative electrode active material particles. A ratio O/Si of the oxygen to the silicon constituting the negative electrode active material particles is in the range of 0.8 or more and 1.2 or less.

Abstract: The present disclosure relates to a non-transitory computer-readable recording medium storing an analysis program that causes a computer to execute a process. The process includes determining whether a resource usage of a machine executing a service exceeds a threshold when the machine processes a request for the service, notifying the machine of the request when it is determined that the resource usage does not exceed the threshold, and scaling out the machine when it is determined that the resource usage exceeds the threshold.

Abstract: An object of the present invention is to provide an effective and safe medicament having effects for mitigating conditions and/or suppressing onset of a peripheral neuropathy induced by administration of an anti-malignant tumor agent, oxaliplatin, in a human cancer patient receiving an anti-malignant tumor treatment with oxaliplatin. There is provided a medicament for mitigating conditions and/or suppressing onset of a peripheral neuropathy induced by oxaliplatin in an anti-malignant tumor treatment consisting of repetition of a single cycle comprising intravenous administration of oxaliplatin to a human cancer patient and following drug withdrawal, which contains thrombomodulin for intravenously administering 0.06 mg/kg of thrombomodulin once per said single cycle of the treatment on the first day of each said cycle as an active ingredient.

Abstract: An object of the present invention is to provide an effective and safe medicament having effects for mitigating conditions and/or suppressing onset of a peripheral neuropathy induced by administration of an anti-malignant tumor agent, oxaliplatin, in a human cancer patient receiving an anti-malignant tumor treatment with oxaliplatin. There is provided a medicament for mitigating conditions and/or suppressing onset of a peripheral neuropathy induced by oxaliplatin in an anti-malignant tumor treatment consisting of repetition of a single cycle comprising intravenous administration of oxaliplatin to a human cancer patient and following drug withdrawal, which contains thrombomodulin for intravenously administering 0.06 mg/kg of thrombomodulin once per said single cycle of the treatment on the first day of each said cycle as an active ingredient.

Abstract: The invention provides a foldable electronic device comprising a main body and a closure connected to each other openably. A frame 6 is provided inside the closure and holds therein a main display 4 and a subdisplay 5 as arranged back to back. A chip mount area 42 of a flexible lead 41 extending from the main display 4 and a chip mount area 53 of a flexible lead 51 extending from the subdisplay 5 are opposed to each other in an opening formed in the frame 6. Opposed surfaces of the respective chip mount areas 42, 53 have groups of electronic circuit chips 43, 54 mounted thereon as positioned in a staggered relation with each other.

Abstract: The invention provides a foldable electronic device comprising a main body and a closure connected to each other openably. A frame 6 is provided inside the closure and holds therein a main display 4 and a subdisplay 5 as arranged back to back. A chip mount area 42 of a flexible lead 41 extending from the main display 4 and a chip mount area 53 of a flexible lead 51 extending from the subdisplay 5 are opposed to each other in an opening formed in the frame 6. Opposed surfaces of the respective chip mount areas 42, 53 have groups of electronic circuit chips 43, 54 mounted thereon as positioned in a staggered relation with each other.